Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to enroll all patients evaluated at the specialized Cardiogenetic Center within the Cardiology Department of the University of Ferrara, Italy. The primary aim of the registry is to collect comprehensive clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. By systematically documenting patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes, the registry seeks to enhance our understanding of the genetic basis and clinical implications of genetically driven arrhythmias and systemic syndromes. This registry will facilitate long-term follow-up of enrolled patients to assess the natural history of arrhythmogenic disorders and the effectiveness of various therapeutic interventions. Additionally, it aims to identify potential risk factors associated with adverse outcomes, such as sudden cardiac death or major arrhythmic events.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.

• Having a proven cardiogenetic disease

Locations
Other Locations
Italy
Department of Cardiology, University Hospital of Ferrara
RECRUITING
Ferrara
Contact Information
Primary
Cristina Balla, MD PhD
bllcst@unife.it
+39 0532 239886
Time Frame
Start Date: 2017-11-01
Estimated Completion Date: 2035-11-01
Participants
Target number of participants: 200
Treatments
Patients with cardiogenetic disease
Related Therapeutic Areas
Sponsors
Leads: University Hospital of Ferrara

This content was sourced from clinicaltrials.gov